Iproniazide is an antidepressant medication used to treat symptoms of depression. It belongs to a class of drugs called monoamine oxidase inhibitors (MAOIs). Iproniazide works by increasing the levels of certain chemicals in the brain, such as serotonin, norepinephrine, and dopamine, which help to improve mood. It is usually taken once or twice daily and is available in tablet form. Common side effects include dry mouth, nausea, dizziness, and insomnia.
Iproniazid is a substance with a significant historical role in medicine but is no longer widely used due to safety concerns. Here's a breakdown of its characteristics:
- Type of drug: Iproniazid is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) belonging to the hydrazine class.
- Original purpose: It was initially developed in the 1950s to treat tuberculosis.
- Later discovery: Researchers observed that patients taking Iproniazid exhibited mood improvement, leading to its introduction as the first-ever antidepressant medication in 1958.
- Reason for withdrawal: Unfortunately, Iproniazid was subsequently withdrawn from the market due to its severe side effects, particularly causing liver damage (hepatotoxicity).
Safer and more effective medications have replaced Iproniazid for both tuberculosis and depression treatment.
Important Note: Iproniazid is not a medication currently prescribed due to the availability of safer and more effective alternatives. This information is for informational purposes only and should not be interpreted as medical advice.